| 证券代码 | OACQ.O |
| 证券名称 | Origo Acquisition Corp |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2015-01-07 |
| 首发价格(元) | 10 |
| 首发数量(股) | 4000000 |
| 首发募资额(元) | 40,000,000.00 |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Origo Acquisition Corporation |
| 注册地址 | 开曼群岛 |
| 办公地址 | 708 Third Avenue, New York, New York, USA |
| 成立日期 | 2014-08-26 |
| 董事会主席 | Adam E. Levin |
| 公司属地 | Cayman Islands 开曼群岛（英属） |
| 公司网址 | - |
| 电话 | +1 (212) 634-4512 |
| 传真 | - |
| 公司简介 | Origo Acquisition Corporation is a blank check company formed on August 26, 2014 under the name CB Pharma Acquisition Corp. for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company’s efforts in identifying a prospective target business is not limited to a particular industry or geographic region of the world. |